Rare diseases
Investigational molecules
Locations
Back to France3 344 clinical trials in Saint-Cloud, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
FranceStudy on Volixibat for Treating Itching in Patients with Primary Biliary Cholangitis
FranceStudy of Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer
FranceStudy Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma
FranceStudy on SOT102 for Patients with Advanced Gastric and Pancreatic Cancer, Alone or with Drug Combination
FranceStudy of Regorafenib with Chemotherapy for Newly Diagnosed Patients with Metastatic Ewing Sarcoma
FranceStudy on the Safety and Effectiveness of SerpinPC for Patients with Hemophilia B with Inhibitors
FranceStudy of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery
FranceStudy of Pembrolizumab, Paclitaxel, and Bevacizumab for Patients with Platinum-Resistant Recurrent Ovarian Cancer
FranceStudy of Radiotherapy with Cetuximab and Xevinapant for Patients with Advanced Head and Neck Cancer Unfit for High-Dose Cisplatin
FranceStudy of Pembrolizumab and Lenvatinib for Patients with Advanced Non-Clear Cell Kidney Cancer
FranceStudy of Olaparib and Pembrolizumab for Patients with Advanced Cancer with HRRm or HRD Mutations
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on lymphoma and multiple myeloma treatments, including studies of novel therapies like duvelisib for T-cell lymphoma and odronextamab for follicular lymphoma.
Several studies are evaluating combination therapies and comparing new treatment approaches against standard care.
Comprehensive research into various types of breast cancer, with particular focus on hormone receptor-positive and triple-negative variants. Studies include early detection methods and novel therapeutic combinations.
Trials incorporate innovative approaches like ctDNA monitoring and targeted therapies.
Research focusing on targeted therapies for various advanced cancers, including studies of biliary tract cancer and non-small cell lung cancer treatments.
Emphasis on immunotherapy combinations and precision medicine approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
